Showing results (2131-2140 of 2,866) with videos related to

Sort By:
Pageof 287
Frontiers in Oncology|September 17, 2024
External validation of hemoglobin and neutrophil levels as predictors of the effectiveness of ipilimumab plus nivolumab for treating renal cell carcinomaShuzo Hamamoto, Yoshihiko Tasaki, Shimpei Yamashita, et al.
Pediatric Nephrology (Berlin, Germany)|February 15, 2025
Second kidney transplant during childhood: clinical aspects, outcomes, and risk factors for graft survivalLuciana de Santis Feltran, Fernando Kazuaki Hamamoto, Camila Penteado Genzani, et al.
NPJ Digital Medicine|February 11, 2025
Establishment of a machine learning model for predicting splenic hilar lymph node metastasisKenichi Ishizu, Satoshi Takahashi, Nobuji Kouno, et al.
Japanese Journal of Clinical Oncology|September 10, 2013
Randomized Phase III study of 5-fluorouracil continuous infusion vs. sequential methotrexate and 5-fluorouracil therapy in far advanced gastric cancer with peritoneal metastasis (JCOG0106)Kuniaki Shirao, Narikazu Boku, Yasuhide Yamada, et al.
The Neuroradiology Journal|September 25, 2013
Striatal Distribution of Dopamine Transporters and Dopamine D2 Receptors at Different Stages of Parkinson's Disease. A CFT and RAC PET StudyM Mishina, K Ishii, M Suzuki, et al.
Scientific Reports|March 21, 2018
Delta-like 3 is silenced by HBx via histone acetylation in HBV-associated HCCsHiroki Hamamoto, Kentaro Maemura, Kentaro Matsuo, et al.
Abdominal Radiology (New York)|June 11, 2024
Unveiling the mille-feuille sign: a key to diagnosing ovarian carcinosarcoma in addition to ovarian metastasis from colorectal carcinoma on MRIYuriko Watanabe, Mitsuru Matsuki, Akihiro Nakamata, et al.
Biomolecules|October 22, 2020
Predicting Deep Learning Based Multi-Omics Parallel Integration Survival Subtypes in Lung Cancer Using Reverse Phase Protein Array DataSatoshi Takahashi, Ken Asada, Ken Takasawa, et al.
Molecular Cancer Therapeutics|February 23, 2018
Pharmacological and Structural Characterizations of Naquotinib, a Novel Third-Generation EGFR Tyrosine Kinase Inhibitor, in EGFR-Mutated Non-Small Cell Lung CancerToshiyuki Hirano, Hiroyuki Yasuda, Junko Hamamoto, et al.
Japanese Journal of Clinical Oncology|February 3, 2016
Inter-institutional survival heterogeneity in chemoradiation therapy for esophageal cancer: exploratory analysis of the JCOG0303 studyYasuo Hamamoto, Junki Mizusawa, Hiroshi Katayama, et al.
Pageof 287